Recent Happenings

Female CEO Fireside Chat at FC featuring Angie You, PhD, Laura Shawver, PhD, and Carol Gallagher PharmD

Last month at Founders Corner, we had the privilege of hosting a panel discussion featuring Dr. Angie You and Dr. Laura Shawver, moderated by Dr. Carol Gallagher. The event was a celebration of women’s achievements in the industry, uniting early-stage founders and seasoned industry leaders. We learned about the challenges and insecurities that take place when running

Female CEO Fireside Chat at FC featuring Angie You, PhD, Laura Shawver, PhD, and Carol Gallagher PharmD Read More »

Personal.ai Presents at FC with AI x BIO

We really enjoyed the lightning talk ⚡️ with Personal.ai Co-Founder & CTO Sharon Zhang recently where she took a deep dive into the evolution of their AI’s capabilities. Fascinating stuff, extremely helpful for entrepreneurs looking to become efficient and for those looking to memorialize and access important data in a meaningful way. Thanks to the hosts Neal Bloom, Arjun Bansal, Nick Edwards,

Personal.ai Presents at FC with AI x BIO Read More »

Orphagen’s Scott Thacher, Haiyan Tao, and Paul Crowe Present to FC

Great turnout at the Founders Corner and excellent presentation from the Orphagen Pharmaceuticals team – Scott Thacher, Haiyan Tao, Paul Crowe. Thank you to the mentors who carved out time this afternoon to provide insightful feedback on strategy and positioning. Orphagen is a pioneer in the screening, discovery and development of ligands that modulate orphan or unexplored members of the nuclear

Orphagen’s Scott Thacher, Haiyan Tao, and Paul Crowe Present to FC Read More »

Palm Therapeutics’ Andrew Rudd Presents to FC

Thank you to Andrew Rudd of Palm Therapeutics for his presentation to FCVC and a special thanks to our FC mentors for carving out time to provide valuable feedback around strategy and positioning. Palm Therapeutics is a San Diego-based biotech startup (JLABS Resident) developing first-in-class palmitoylation inhibitors in the oncology space. Currently raising a seed

Palm Therapeutics’ Andrew Rudd Presents to FC Read More »

Chimeris’ Chris Bird Presents to FC

Chimeris addresses pain points of existing cell therapies. Dr. Christopher Bird- Co-Founder and Co-CEO Dr. Bird has his PhD in Molecular Immunology from Oxford University • CMO of BioPorto Diagnostics, a public company in Denmark and the US, responsible for clinicaldevelopment for all markets, regulatory oversight, safety and quality;• Head of North America Medical and

Chimeris’ Chris Bird Presents to FC Read More »